MC Toxicology Consulting is specialized in early stage drug development with a focus on regulatory strategy, toxicology, pharmacology, and pharmacokinetics. We also directly help our clients with high quality, hands-on operational support for the execution of non-clinical development programs. MC Toxicology Consulting was incorporated in 2006 around its core expertise in non-clinical regulatory and toxicology, with an initial focus on small molecules and biologics. Since then the area of expertise has steadily extended and now encompasses, in particular, advanced therapy medicinal products (ATMPs), including gene and gene-editing therapies.

Clients, both small- and mid-sized biotech as well as large pharma, are mainly based in Europe and North America, but also in the Middle East and South East Asia. MC Toxicology Consulting is proud of having served more than 200 companies since its inception, supporting many of them for years. The company continues to build on its key success factor, i.e. to offer focused, boutique consulting by putting highest quality and tailored services first. In addition, the company has built over the years an easy to access network of highly specialized experts in various fields.